Cara Therapeutics
CARA
#9640
Rank
NZ$27.3 M
Marketcap
$0.50
Share price
-4.32%
Change (1 day)
-75.33%
Change (1 year)

Cara Therapeutics (CARA) - P/B ratio

P/B ratio as of November 2024 : 1.39

According to Cara Therapeutics 's latest financial reports the company has a price-to-book ratio of 1.46244.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Cara Therapeutics - P/B ratio (from 2014 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-310.7091-80.49%
2022-12-313.6327%
2021-12-312.86-5.49%
2020-12-313.03-24.89%
2019-12-314.034.78%
2018-12-313.85-16.35%
2017-12-314.60-7.95%
2016-12-315.0014.22%
2015-12-314.37-0.59%
2014-12-314.40
2013-12-31N/A
2012-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
-0.0900-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
1.03-25.45%๐Ÿ‡บ๐Ÿ‡ธ USA
1.82 31.15%๐Ÿ‡บ๐Ÿ‡ธ USA
5.51 297.49%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.0044-100.32%๐Ÿ‡บ๐Ÿ‡ธ USA